Evidence map›Paper›PMID 25297918›Full record

ReviewCellular and molecular life sciences : CMLS2014

Interplay between genetic and epigenetic factors governs common fragile site instability in cancer.

Efrat Ozeri-Galai, Michal Tur-Sinai, Assaf C Bester, Batsheva Kerem

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Replication of [AT/TA]Biochemistry · 2024
    Article
  2. Replication of [AT/TA]bioRxiv : the preprint server for biology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Rescue from replication stress during mitosis.Cell cycle (Georgetown, Tex.) · 2017
    Review
  10. Review
  11. Fragility Extraordinaire: Unsolved Mysteries of Chromosome Fragile Sites.Advances in experimental medicine and biology · 2017
    Review
  12. Review
  13. Article
  14. Mechanisms of gene targeting in higher eukaryotes.Cellular and molecular life sciences : CMLS · 2016
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Efrat Ozeri-GalaiDepartment of Genetics, The Life Sciences Institute, The Hebrew University, Edmond J. Safra Campus, 91904, Jerusalem, Israel.
Michal Tur-Sinai
Assaf C Bester
Batsheva Kerem
Hebrew University of Jerusalem · ILHebrew College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common fragile sites (CFSs) are regions within the normal chromosomal structure that were characterized as hotspots for genomic instability in cancer almost 30 years ago. In recent years, many efforts have been made to understand the basis of CFS fragility and their involvement in the genomic signature of instability found in malignant tumors. CFSs are among the first regions to undergo genomic instability during cancer development because of their intrinsic sensitivity to replication stress conditions, which result from oncogene expression. The preferred sensitivity of CFSs to replication stress stems from various mechanisms including: replication fork arrest at AT-rich repeats, origin paucity along large genomic regions, failure in activation of dormant origins, late replication timing, collision between replication and transcription along large genes, all leading to incomplete replication of the CFS region and resulting in chromosomal instability. Here we review shared and unique characteristics of CFSs, their underlying causes and implications, particularly for the development of cancer.

Indexed as

Chromosome Fragile SitesEpigenesis, GeneticGene Expression Regulation, NeoplasticGenomic InstabilityAnimalsDNA DamageHumansNeoplasms

Identifiers

PMID25297918
PMCPMC11113459
OpenAlexW2062310052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.